EFFICACY AND SAFETY OF LONG TERM CYCLOPHOSPHAMIDE TREATMENT FOR INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS

被引：2
|
作者：
Kwon, H. M. [1 ]
Karig, E. H. [1 ]
Go, D. J. [1 ]
Park, J. K. [1 ]
Lee, E. Y. [1 ]
Song, Y. W. [1 ]
Lee, H. -J. [2 ]
Lee, E. B. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[2] Seoul Natl Univ, Coll Med, Radiol, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.4302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0621
引用
收藏
页码：1011 / 1011
页数：1
相关论文
共 50 条
  • [41] Interstitial lung disease in systemic sclerosis
    Bussone, Guillaume
    Mouthon, Luc
    AUTOIMMUNITY REVIEWS, 2011, 10 (05) : 248 - 255
  • [42] Interstitial lung disease in systemic sclerosis
    Mouthon, L.
    Berezne, A.
    Brauner, M.
    Kambouchner, M.
    Guillevin, L.
    Valeyre, D.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : 1035 - 1046
  • [43] Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease
    Khanna, Dinesh
    Albera, Carlo
    Fischer, Aryeh
    Seibold, James R.
    Khalidi, Nader A.
    Raghu, Ganesh
    Chung, Lorinda
    Schiopu, Elena
    Chen, Dan
    Gorina, Eduard
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [44] Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
    Mohammed, Abdel Gaffar A.
    Alshihre, Ammar
    Al-Homood, Ibrahim Abdulrazag
    ANNALS OF THORACIC MEDICINE, 2017, 12 (04) : 294 - 297
  • [45] Interstitial lung disease in systemic sclerosis: current and future treatment
    Giacomelli, Roberto
    Liakouli, Vasiliki
    Berardicurti, Onorina
    Ruscitti, Piero
    Di Benedetto, Paola
    Carubbi, Francesco
    Guggino, Giuliana
    Di Bartolomeo, Salvatore
    Ciccia, Francesco
    Triolo, Giovanni
    Cipriani, Paola
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (06) : 853 - 863
  • [46] Treatment of systemic sclerosis-associated interstitial lung disease
    Prasse, A.
    Bonella, F.
    Mueller-Ladner, U.
    Witte, T.
    Hunzelmann, N.
    Distler, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 294 - 303
  • [47] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
  • [48] Rituximab for the treatment of systemic sclerosis-interstitial lung disease
    Hughes, Michael
    Denton, Christopher P.
    Khanna, Dinesh
    RHEUMATOLOGY, 2021, 60 (02) : 489 - 491
  • [49] Interstitial lung disease in systemic sclerosis: current and future treatment
    Roberto Giacomelli
    Vasiliki Liakouli
    Onorina Berardicurti
    Piero Ruscitti
    Paola Di Benedetto
    Francesco Carubbi
    Giuliana Guggino
    Salvatore Di Bartolomeo
    Francesco Ciccia
    Giovanni Triolo
    Paola Cipriani
    Rheumatology International, 2017, 37 : 853 - 863
  • [50] The efficacy of immunosuppressive agents for interstitial lung disease in systemic sclerosis.
    Nam, EJ
    Seo, JS
    Cho, JH
    Kim, SU
    Han, SW
    Bae, KS
    Jeon, KN
    Kang, YM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S163 - S163
12345